HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study

被引:0
作者
Marta Grau-Vorster
Anita Laitinen
Johanna Nystedt
Joaquim Vives
机构
[1] Edifici Dr. Frederic Duran i Jordà,Servei de Teràpia Cel·lular, Banc de Sang i Teixits
[2] Universitat Autònoma de Barcelona,Transfusion Medicine Group, Vall d’Hebron Research Institute (VHIR)
[3] Advanced Cell Therapy Centre,Finnish Red Cross Blood Service
[4] Universitat Autònoma de Barcelona,Musculoskeletal Tissue Engineering Group, Vall d’Hebron Research Institute (VHIR)
[5] Universitat Autònoma de Barcelona,Departament de Medicina
来源
Stem Cell Research & Therapy | / 10卷
关键词
Multipotent mesenchymal stromal cell; Potency; Identity; HLA-DR; Cellular therapy; Cell culture; Quality compliance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 119 条
[11]  
Rasko JEJ(2016)A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells Cytotechnology. 68 891-3416
[12]  
Koh MBC(2017)A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies J Tissue Eng Regen Med 11 3408-2B 9 22
[13]  
Dominici M(2018)Derivation of multipotent mesenchymal stromal cells from ovine bone marrow Curr Protoc Stem Cell Biol 44 2B 9 1-44
[14]  
Ikonomou L(2018)Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cells Cytotechnology. 70 31-1833
[15]  
Galipeau J(2008)Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA J Immunol 180 1826-145
[16]  
Sensebe L(2014)MSC-based product characterization for clinical trials: an FDA perspective Cell Stem Cell 14 141-896
[17]  
Dominici M(2003)HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells Exp Hematol 31 890-240
[18]  
Le Blanc K(2016)Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment J Inflamm Res 9 231-617
[19]  
Mueller I(2000)Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44 and CD54) by cultured human osteoblasts J Periodontol 71 614-undefined
[20]  
Slaper-Cortenbach I(2005)Mesenchymal stem cells avoid allogeneic rejection J Inflamm (Lond) 2 8-undefined